Table of Contents
I. The Tobacco Regulatory Science Program (TRSP)
II. Notices from NIDA HIV/AIDS Program
I. The Tobacco Regulatory Science Program (TRSP)
The Tobacco Regulatory Science Program (TRSP) is an interagency partnership between the NIH and the FDA Center for Tobacco Products to foster tobacco regulatory research. With the passage of the 2009 Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act), the FDA acquired the authority to regulate the manufacture, marketing, and distribution of tobacco products in order to protect public health. Within the framework of the Tobacco Control Act, the NIH and FDA formed this partnership to establish a comprehensive research agenda in tobacco regulatory science.
TRSP offers several research funding opportunities focused on tobacco regulatory science. Investigator-initiated applications may also be submitted for NIH review. As you review the grant opportunities:
- Review the current TRSP Research Priorities page for topics relevant to the FDA Center for Tobacco Products.
- Work with the NIH Program Officials listed in Section VII: NIH Agency Contacts of the Funding Opportunity Announcement (FOA) or Contact the NIH TRSP Mailbox.
- Learn about the application review process. Note that the TRSP review criteria are different from the standard NIH review criteria.
Find a list of current TRSP funding opportunities copied below:
Tobacco Regulatory Science Program (TRSP) Funding Opportunities and Announcements
• The Tobacco Regulatory Science (R01 Clinical Trial Optional) - RFA-OD-19-028 has been reissued with new research priorities. The next application date is February 13, 2021. LOI due 60 days prior to the application due date.
• Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 - Clinical Trial Not Allowed) - RFA-OD-19-022. The next application date is March 8, 2021. LOI due 60 days prior to the application due date.
• Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 - Clinical Trial Not Allowed) - RFA-OD-19-021. The next application date March 8, 2021. LOI due 60 days prior to the application due date.
· The K01 and K99/R00 RFAs were re-issued. The next application due date is February 8, 2021. LOI due 60 days prior to the application due date.
· Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01)
o RFA-OD-20-008 non-clinical trial
o RFA-OD-20-011 clinical trial
· Pathway to Independence Award in Tobacco Regulatory Research (K99/R00)
o RFA-OD-20-009 non-clinical trial
o RFA-OD-20-010 clinical trial
- NOSI: Research to Advance the Understanding of Tobacco Product Pharmacokinetic Research - NOT-OD-20-081. This notice applies to due dates after July 17, 2020 and subsequent receipt dates through February 13, 2021.
· For additional information on TRSP funding opportunities, visit the TRSP website
II. Notices from NIDA HIV/AIDS Program
- * Notice of Participation of the National Institute on Drug Abuse(NIDA) in PA-19-042, "Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional)"
(NOT-DA-20-095)
National Institute on Drug Abuse
- * Notice of Participation of the National Institute on Drug Abuse(NIDA) in PA-19-050, "Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional)"
(NOT-DA-20-096)
National Institute on Drug Abuse
- * Notice of Participation of the National Institute on Drug Abuse(NIDA) in RFA-MD-21-001, "Multi-Level HIV Prevention Interventions for Individuals at the Highest Risk of HIV Infection (R01 Clinical Trial Optional)"
(NOT-DA-21-009)
National Institute on Drug Abuse
- * Notice of Participation of the National Institute on Drug Abuse(NIDA) in RFA-MD-21-002, "Promoting Viral Suppression among Individuals from Health Disparity Populations Engaged in HIV Care (R01 Clinical Trial Required)"
(NOT-DA-21-010)
National Institute on Drug Abuse
------------------
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L
No comments:
Post a Comment